Ambu stock

AMBU.B · Nasdaq Copenhagen · DKK

Compare Ambu
kr 91.90Change from previous close: +0.27%Absolute change: +kr 0.25

Close · November 16, 2026

Price history

+7.67% over the period

1 year: from kr 85.35 (November 17, 2025) to kr 91.90 (November 16, 2026), +7.67%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026kr 91.90
October 30, 2026kr 81.20
September 30, 2026kr 68.95
August 31, 2026kr 71.15
July 31, 2026kr 72.35
June 30, 2026kr 61.00
May 29, 2026kr 67.40
April 30, 2026kr 63.05
March 31, 2026kr 68.40
February 27, 2026kr 79.50
January 30, 2026kr 85.10
December 30, 2025kr 88.00
November 28, 2025kr 87.30
November 17, 2025kr 85.35

At a glance

TickerLandia's take on Ambu

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 56.25
52-wk highkr 93.25

−1.45% from the 52-week high

Analysts · 8 analysts

Average targetkr 95.04+3.41% vs. price

Buy 2 · Hold 5 · Sell 1 · Hold

TickerLandia Fingerprint: Ambu

Compared with similar companies: very low dividend, very high risk, and very high growth.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Ambu is cheaper than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Ambu's P/E today is 40.3, below the median of its last 10 fiscal years (114.4; between 40.6 and 193.7 from 2016 to 2025). Ambu's P/E (trailing 12 months): 38.0, +25% against the median of a group of 10 similar companies (30.3).

P/E compared with its history

Compared with 10 similar companies

Ambu's metrics compared with similar companies
MetricAmbuPosition in the groupBand
P/E (trailing 12 months)38.0Middle
Forward P/E23.9Middle
Operating margin13.2%Low
ROE10.5%Middle
Debt/equity0.09Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Ambu. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 1.64B

Latest quarter · Q2 2026

Net income

kr 156M

Latest quarter · Q2 2026

Quarterly net margin

9.5%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
kr 23.99B
P/E
38.0
EPS
kr 2.42
Volume
236.96K
Daily trading
€9.39M
Dividend yield
0.45%

How Ambu is changing

All results
  • Revenue grew 11.1% a year on average over the last 5 years

  • Operating margin rose from 2.7% to 13.0%

  • Profits turn into cash: free cash flow equal to 182% of net income

Returns

Ambu returns with dividends

kr 1,000 invested in Ambu 5 years ago, on November 16, 2021, would be worth kr 504 today with dividends reinvested: −49.58% in total, −12.80% per year. On price alone it would be kr 499 (−50.07%).

PeriodAmbukr 1,000 becomes
1 month+17.29%kr 1,173
6 months+47.16%kr 1,472
Year to date+4.43%kr 1,044
1 year+8.18%kr 1,082
3 years+4.01%kr 1,040
5 years−49.58%kr 504
10 years+55.95%kr 1,560

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Ambu: technical analysis

Ambu shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 74.1% below its all-time closing high (kr 355.40, April 27, 2021).

Trend
No clear trend
RSI (14 sessions)
76
Above 70: a strong rise in a short time
vs 200-session average
+28.32%

Active signals

  • RSI above 70: the stock has risen a lot in a short time.

    since November 13, 2026

Support and resistance

Price areas where Ambu has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistancekr 92.70+0.87%2 touches, last on November 5, 2026
  2. Last pricekr 91.90
  3. Supportkr 89.04−3.11%4 touches, last on February 4, 2026
  4. Supportkr 86.25−6.15%2 touches, last on January 5, 2026
  5. Supportkr 85.00−7.51%3 touches, last on January 20, 2026

Volatility and risk

Volatility (60 sessions, annualised)
48.5%
Largest fall in the last year
−35.45%

In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Ambu: seasonality

Average monthly price change over 23 years

+5.9%Jan+1.7%Feb+1.3%Mar+4.0%Apr+2.7%May−1.9%Jun+2.1%Jul−0.9%Aug−2.1%Sep+2.0%Oct+2.4%Nov+6.6%Dec

Over the last 23 years, the strongest month for Ambu has been December: +6.58% on average, positive in 17 years out of 22. The weakest has been September: −2.06% on average, positive in 9 years out of 23. November, the current month, has been positive in 15 years out of 22 (+2.43% on average).

Show chart data
MonthAverageMedianPositive years
January+5.94%+7.49%18 of 22
February+1.68%−1.31%10 of 22
March+1.26%+0.50%12 of 23
April+4.04%+3.96%15 of 23
May+2.70%+1.77%13 of 23
June−1.90%−1.39%10 of 23
July+2.08%+0.75%13 of 23
August−0.91%−1.55%9 of 23
September−2.06%−2.16%9 of 23
October+2.02%−1.15%10 of 23
November+2.43%+4.05%15 of 22
December+6.58%+4.56%17 of 22

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Ambu and its competitors

Endoscopy products lead the company's range, covering bronchoscopes, video laryngoscopes, gastroscopes, cystoscopes and ureteroscopes, along with the displaying and processing units that accompany them. The company also sells neurology devices, including EEG and EMG electrodes and intraoperative monitoring products, plus ECG electrodes for cardiology. Airway management and anaesthesia tubes, masks and resuscitators, emergency care equipment and training manikins complete the offering, which is sold in North America, Europe and other international markets.

Headquarters
Ballerup, Denmark
Employees
4,664
Founded
1937
Chief executive
Britt Jensen
Ambu and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
AmbuAMBU.B$3.55B13.2%38.0+47.16%
Medacta GroupMOVE$2.57B15.2%30.2−22.11%
GN Store NordGN$2.57B10.9%90.2+25.93%
ElektaEKTA.B$2.37B9.2%—+15.05%
SectraSECT.B$6.17B20.6%99.9+28.26%
ChemoMetecCHEMM$1.85B49.8%63.0+123.20%

Same industry or related industries, similar size. Compare Ambu with its competitors · Full profile